Lexatumumab

Ask supplier a question | View on supplier's website

Lexatumumab is a human monoclonal agonistic antibody directed against TRAIL-R2. Lexatumumab binds to TRAIL-R2 thus inducing apoptosis of TRAIL-R2-expressing tumor cells.

Supplier	BOC Sciences
Product #	845816-02-6
Pricing	Inquire
Cas	845816-02-6
Molecular Weight	143.6 kDa
Molecular Formula	C6346H9832N1720O2002S42

Feedback